These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 28292640)

  • 21. Magnetic resonance enterography changes after antibody to tumor necrosis factor (anti-TNF) alpha therapy in Crohn's disease: correlation with SES-CD and clinical-biological markers.
    Stoppino LP; Della Valle N; Rizzi S; Cleopazzo E; Centola A; Iamele D; Bristogiannis C; Stoppino G; Vinci R; Macarini L
    BMC Med Imaging; 2016 May; 16(1):37. PubMed ID: 27149857
    [TBL] [Abstract][Full Text] [Related]  

  • 22. David Against Goliath: Direct Comparison of Handheld Bowel Sonography and Magnetic Resonance Enterography for Diagnosis of Crohn's Disease.
    Rispo A; de Sire R; Mainenti PP; Imperatore N; Testa A; Maurea S; Ricciolino S; Nardone OM; Olmo O; Castiglione F
    Inflamm Bowel Dis; 2023 Apr; 29(4):563-569. PubMed ID: 35666249
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clinical remission and transmural healing of ustekinumab in patients with Crohn's disease].
    Wu Y; Xu Y; Zhang G; Zhang Y; Wang J; You P; Peng T; Liu Y; Chen N
    Beijing Da Xue Xue Bao Yi Xue Ban; 2024 Apr; 56(2):253-259. PubMed ID: 38595241
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mucosal healing is associated with improved long-term outcome of maintenance therapy with natalizumab in Crohn's disease.
    Sakuraba A; Annunziata ML; Cohen RD; Hanauer SB; Rubin DT
    Inflamm Bowel Dis; 2013 Nov; 19(12):2577-83. PubMed ID: 24132161
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Magnetic Resonance Enterography Healing and Magnetic Resonance Enterography Remission Predicts Improved Outcome in Pediatric Crohn Disease.
    Sauer CG; Middleton JP; McCracken C; Loewen J; Braithwaite K; Alazraki A; Martin DR; Kugathasan S
    J Pediatr Gastroenterol Nutr; 2016 Mar; 62(3):378-83. PubMed ID: 26348683
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ultrasound Elasticity Imaging Predicts Therapeutic Outcomes of Patients With Crohn's Disease Treated With Anti-Tumour Necrosis Factor Antibodies.
    Orlando S; Fraquelli M; Coletta M; Branchi F; Magarotto A; Conti CB; Mazza S; Conte D; Basilisco G; Caprioli F
    J Crohns Colitis; 2018 Jan; 12(1):63-70. PubMed ID: 28961950
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Achievement of deep remission during scheduled maintenance therapy with TNFα-blocking agents in IBD.
    Molander P; Sipponen T; Kemppainen H; Jussila A; Blomster T; Koskela R; Nissinen M; Rautiainen H; Kuisma J; Kolho KL; Färkkilä M
    J Crohns Colitis; 2013 Oct; 7(9):730-5. PubMed ID: 23182163
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Usefulness of abdominal ultrasonography in the analysis of endoscopic activity in patients with Crohn's disease: changes following treatment with immunomodulators and/or anti-TNF antibodies.
    Moreno N; Ripollés T; Paredes JM; Ortiz I; Martínez MJ; López A; Delgado F; Moreno-Osset E
    J Crohns Colitis; 2014 Sep; 8(9):1079-87. PubMed ID: 24613399
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Trefoil factor-3 is not a useful marker of mucosal healing in Crohn's disease treated with anti-TNF-α antibodies.
    Eder P; Stawczyk-Eder K; Korybalska K; Czepulis N; Luczak J; Lykowska-Szuber L; Krela-Kazmierczak I; Linke K; Witowski J
    World J Gastroenterol; 2017 Jan; 23(1):135-140. PubMed ID: 28104989
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Noninvasive diagnosis of small bowel Crohn's disease: direct comparison of bowel sonography and magnetic resonance enterography.
    Castiglione F; Mainenti PP; De Palma GD; Testa A; Bucci L; Pesce G; Camera L; Diaferia M; Rea M; Caporaso N; Salvatore M; Rispo A
    Inflamm Bowel Dis; 2013 Apr; 19(5):991-8. PubMed ID: 23429465
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Magnetic resonance enterography of Crohn's disease.
    Naganuma M; Hisamatsu T; Kanai T; Ogata H
    Expert Rev Gastroenterol Hepatol; 2015 Jan; 9(1):37-45. PubMed ID: 25186521
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Defining Magnetic Resonance Imaging Treatment Response and Remission in Crohn's Disease: A Systematic Review.
    Caron B; Jairath V; Laurent V; Stoker J; Laghi A; D'Haens GR; Danese S; Peyrin-Biroulet L
    J Crohns Colitis; 2024 Jan; 18(1):162-170. PubMed ID: 37523157
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Correlation and concordance measures between clinical, endoscopic and histological scores activity in Crohn's disease under treatment.
    Tajra JB; Calegaro JU; de Paula AP; Bachour D; Silveira D; Lozi M; Cavalcanti H
    Scand J Gastroenterol; 2019 Apr; 54(4):441-445. PubMed ID: 30939952
    [No Abstract]   [Full Text] [Related]  

  • 34. Distinctive histopathologic phenotype in resection specimens from patients with Crohn's disease receiving anti-TNF-α therapy.
    Schaeffer DF; Walsh JC; Kirsch R; Waterman M; Silverberg MS; Riddell RH
    Hum Pathol; 2014 Sep; 45(9):1928-35. PubMed ID: 25022570
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Validity of Contrast-enhanced Ultrasonography and Dynamic Contrast-enhanced MR Enterography in the Assessment of Transmural Activity and Fibrosis in Crohn's Disease.
    Wilkens R; Hagemann-Madsen RH; Peters DA; Nielsen AH; Nørager CB; Glerup H; Krogh K
    J Crohns Colitis; 2018 Jan; 12(1):48-56. PubMed ID: 28981627
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Monitoring Crohn's disease during anti-TNF-α therapy: validation of the magnetic resonance enterography global score (MEGS) against a combined clinical reference standard.
    Prezzi D; Bhatnagar G; Vega R; Makanyanga J; Halligan S; Taylor SA
    Eur Radiol; 2016 Jul; 26(7):2107-17. PubMed ID: 26433956
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A prospective 52 week mucosal healing assessment of small bowel Crohn's disease as detected by capsule endoscopy.
    Hall B; Holleran G; Chin JL; Smith S; Ryan B; Mahmud N; McNamara D
    J Crohns Colitis; 2014 Dec; 8(12):1601-9. PubMed ID: 25257546
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-TNF therapy is able to stabilize bowel damage progression in patients with Crohn's disease. A study performed using the Lémann Index.
    Bodini G; Giannini EG; De Maria C; Dulbecco P; Furnari M; Marabotto E; Savarino V; Savarino E
    Dig Liver Dis; 2017 Feb; 49(2):175-180. PubMed ID: 27864028
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inflammatory mesenteric fat detected by Intestinal ultrasound is correlated with poor long-term clinical outcomes in patients with Crohn's disease.
    Cheng W; Huang Z; Qin S; Liang Z; Gao X; Liu G; Guo Q
    Dig Liver Dis; 2024 May; 56(5):723-729. PubMed ID: 38061972
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diffusion-weighted magnetic resonance enterography for prediction of response to tumor necrosis factor inhibitors in stricturing Crohn's disease.
    Amitai MM; Klang E; Levartovsky A; Rozendorn N; Soffer S; Taha GA; Ungar B; Greener T; Ben-Horin S; Eliakim R; Kopylov U
    Abdom Radiol (NY); 2018 Dec; 43(12):3207-3212. PubMed ID: 29779158
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.